By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss molecular diagnostics developer Diagnoplex today said it has closed a Series A financing extension with Debiopharm Group.

Diagnoplex said today that Debiopharm has committed to invest “a substantial amount” in the company, depending on certain milestones, and has provided half of that commitment up front, although the company did not provide specific financial details about the investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.